RHeum Flashcards
Percentage of patients WITH the disease who have a Positive Test Result
Sensitivity
Percentage of patients Without disease with Negative Test Result
Specificity
What is the classic threshold for an elevated ESR
ESR > 100 generally means significant cancer, serious infection, renal or autoimmune disease
Is CRP relevant in Lupus
No
In chronic rheum d/o what will the complement be..
Hypo
Define spectrum of dz characterized by inflammation of the sacroiliac (SI) joints, spine, or peripheral joints
Spondyloarthropathies or Spondyloarthritis (SpA)
What is the hallmark feature of Ankylosing Spondylitis
Hallmark feature is LBP which improves with activity or exercise, worsens with rest
- Awakens pt at night
- Generally younger than 45 years of age
+Chest Pain
Eye S/s with ankylosing spondylitis
Acute anterior uveitis (inflammation of the iris, ciliary body & choroid) present in up to 50% over the disease course
Most common extra-articular manifestation
Typically abrupt, unilateral, intense pain, redness, photophobia
TTP over the sacral/illeal joint
Think
Ankylosing spondylitis
What would you expect to see on labs in a pt with Ankylosing Spondylitis
CRP elevated in 30-50% of patients with ankylosing spondylitis
Negative RF
Mild, normocytic anemia of chronic disease
Elevated alkaline phosphate
+ HLA-B27
—Not required for diagnosis
Pain greater than 3 months with age less than 45
HLB27 postive w/ >2 SpA features
Or
Sacroillitis and and >1 SpA feature
Think
Ankylosing Spondylitis
SpA features: Inflammatory Back Pain Arthritis Enthesitis Uveitis Dactylitis Psoriasis Crohns Good response to NSIADS FamHx HLBA27 Elevated CRP
What is an independent RSK fx for mortality in Ankylosing spondylitis
Cervical spine fx is an independent predictor of inpatient mortality
Tx approach to Ankylosising Spondylitis
1) NSAIDs
- very good response
2) PT
- 1st line Tx (Active>passive)
3) Steroids
- Directed at the SI joint
4) DMARDs
- Sulfasalazine/ Methotrexate
5) Biologics
- 2nd line, TNF Inhibitors -amaubs
6) Surgery
(Refer, stop smoking, Rhemo and Ortho)
HLBA 27 (Ankylosing Spondylitis) \+ Gastro S/s
Refer to
Gastro (IBD)
And Rheum
What is the common Gastro commorbidity with Arthritis
IBD
Chrons or Ulcerative Colitis
What is the approach to IBD associated Arthritis
NSAIDs avoided as first line because they may lead to exacerbations of IBD.
TNF inhibitors are recommended for active axial ankylosing spondylitis w/ concomitant IBD
Should be co-managed by rheumatology & gastroenterology
Pt that cant pee, cant see, cant bend the knee
Postinfectious Triad:
- Conjunctivitis
- Arthritis
- Urethritis
Dx for Reactive Arthritis
Develops days to weeks following GI/GU infection
Typically Monoarthritis
In a young male pt mc with chlamydia
Hallmark: Enthesitis: inflammation at sites where tendons attach to bone, MC at Achilles
This finding in a pt with reactive arthritis
Keratoderma blennorrhagica:
erythematous macules and vesicles, progressing to papules, hyperkeratotic plaques, and pustules
Classic clinical triad of Reactive Arthritis
Classic Clinical Triad
Conjunctivitis (or uveitis), Urethritis, Oligoarthritis
Pts can also present with a 4th: Mucocutaneous lesions (Apthous)
What is the lab to help R/o septic arthritis and gout for reactive arthritis
Arthrocentesis should be performed to exclude septic arthritis & gout
-Usually WBC counts of 5000-50,000
-Predominantly polymorphonuclear cells and the synovial fluid is sterile (negative Gram stain & culture)
What is the Tx approach to Reactive Arthiritis
NSAIDs: First choice for articular manifestations (ibuprofen/naproxen)
Intra articular glucocorticoids may be considered for peripheral arthritis involving few joints.
Systemic steroids have limited benefit for axial symptoms
Ophthalmology referral if uveitis is present
Antibiotics: Appropriate short term therapy if infection remains active. Does not improve the arthritic symptoms.
Consider DMARD (sulfasalazine or methotrexate) for those that fail NSAIDS and glucocorticoids
Psoriatic Arthritis on X-ray
Radiographic findings of erosions, osteolytic destruction of the interphalangeal joints, and juxta-articular new bone formation
What is a distinguishing feature of psoriatic arthritis
Enthesitis is a distinguishing feature in the pathogenesis of psoriatic arthritis
Psoriatic Arthritis is most common to what joints
Fingers (DIP) with stiffness, swelling, nail pitting
Distinguishes from RA
What are the 5 manifestations for Psoriatic Arthritis
Articular involvement
Dactylitis
(uniform swelling of the digit)
Enthesitis
Skin and nail changes
Extra articular manifestations
-HTN, T2DM, Fatty liver, Occular inflammation, IBD
What is the most common finding in psoriatic arthritis
MC finding is joint –space narrowing & erosions
Distinguished from RA by the absence of juxta-articular osteopenia & presence of pathologic new bone formation
“Pencil-in-cup” (sharpened point) appearance to DIP with Arthritis Mutilans
Periostitis in MCP, MTP, phalanges (“fluffy” appearance)
What is the treatment approach to psoriatic arthritis
Treat the s/s of inflammation
-NSAIDs (1st line
-Steroids ( rheum consult)
-DMARDS (rheum consult)
MC Methotrexate)
RA spares what joint?
DIP and typically spares the spine
When is RA worst
Morning Stiffness
- Hallmark of inflammatory arthritis and RA
- Worse in AM or after prolonged periods of rest
- Lasts for hours and improved with activity
Boutonnière deformity
(“knuckle being pushed through a buttonhole”)
flexion of the PIP joints and hyperextension of the DIP joints
Swan Neck deformity
hyperextension of the PIP joints and flexion at the DIP joints
What is the triad of Fetly Syndrome (RA)
RA
Splenomegaly
Leukopenia
(usually neutropenia, <2000 mm3)
What is the hallmark lab in RA
Anti-CCP antibodies: present 60-70%
Rheumatoid Factor: present ~50% at presentation
How do you start DMARDs for RA
Bridge tx
Takes 2-6 months to read peak effect
Typically 5-10mg prednisone daily while titrating DMARD to effect
What are the ADE of methotrexate
This is the anchor of Rx for RA
ADE: Bone marrow suppression and development of pneumonitis
Hydroxychlorquine
Usually used in conjunction with other synthetic DMARDS (i.e. methotrexate)
-Least toxic, but least effective as stand-alone tx
-Retinal toxicity—uncommon, but serious
-Increased risk over time—cumulative dose
—Initial eye exam and annual eye exams after 5 yrs of tx
Monitor: CBC, LFT, BMP, UA w/ micro-
Leflunomide
DMARDS
Comparable to Methotrexate
-Teratogenic, hepatic toxicity
Monitor: Pregnancy test, CBC, LFT, TB (baseline), hepatitis screening panel (baseline), blood pressure at baseline
Long half life—women need blood tests drawn prior to pregnancy even if stopped med years prior
Use cholestyramine to eliminate leflunomide if woman is considering to become pregnant
What are the 4 things biological DMARDs do
Inhibit Tumor Necrosis Factor
(anti TNF agents)
Deplete CD20+ B Cells
(rituximab)
Inhibit T-Cell costimulation (abatacept)
Block the receptor for interleukin-6 (tocilizumab)
What is the absolute C/I for Biological DMARDs
Active TB or Untreated latent TB is an absolute contraindication to use of biologic DMARDs
Reactivation of latent TB has occurred within weeks of starting anti-TNF agents
Tx approach to RA
RA should be diagnosed early and DMARD started at time of diagnosis
- Treatment goal of remission or low activity
- Meeting treatment goal more important than medication choice
- Most patient will need combo DMARD therapy. Typically methotrexate + something else
NSAIDS and glucocorticioids should be used sparingly as needed or a bridge therapy
DONT FORGET THESE SCREENS FOR RA tx
Consider phone consultation first to initiate therapy until patient is seen
Test for TB, Hepatitis B, C, HIV etc
Immunizations prior to immunosuppression (pneumococcal, flu)
Bridge communication between Rheumatologist and PCM
Define scleroderma
Scleroderma = Hard Skin
-systemic autoimmune disease characterized by varying degrees of skin fibrosis, vascular damage, and a wide array of internal organ dysfunction.
Two Main Manifestations
-Fibrotic dz (skin tightening & interstitial lung dz (ILD)
—Limited cutaneous (confined to fingers, toes & face)
—Diffuse cutaneous (skin tightening extends proximal to elbows, knees & trunk)
Vascular dz (Raynaud phenomenon & pulmonary arterial HTN (PAH)
What are the two prominent S/S in scleroderma
Raynuads and ANA Abs